| Rivastigmine Actavis 4.5 mg hard capsules EU/1/11/693/009-012 |
Rivastigmine hydrogen tartrate |
Actavis Group hf |
— |
| Rivastigmine Actavis 6 mg hard capsules EU/1/11/693/013-016 |
Rivastigmine hydrogen tartrate |
Actavis Group hf |
— |
| Rivastigmine HEXAL 1.5 mg hard capsules EU/1/09/589/1-4 |
Rivastigmine hydrogen tartrate |
Hexal AG |
— |
| Rivastigmine HEXAL 2 mg/ml oral solution EU/1/09/589/017-018 |
Rivastigmine hydrogen tartrate |
Hexal AG |
— |
| Rivastigmine HEXAL 3 mg hard capsules EU/1/09/589/5-8 |
Rivastigmine hydrogen tartrate |
Hexal AG |
— |
| Rivastigmine HEXAL 4.5 mg hard capsules EU/1/09/589/9-12 |
Rivastigmine hydrogen tartrate |
Hexal AG |
— |
| Rivastigmine HEXAL 6 mg hard capsules EU/1/09/589/13-16 |
Rivastigmine hydrogen tartrate |
Hexal AG |
— |
| Rivastigmine Sandoz 1.5 mg hard capsules EU/1/09/599/001-003 |
Rivastigmine hydrogen tartrate |
Sandoz Pharmaceuticals GmbH |
— |
| Rivastigmine Sandoz 2 mg/ml oral solution EU/1/09/599/017-018 |
Rivastigmine hydrogen tartrate |
Sandoz Pharmaceuticals GmbH |
— |
| Rivastigmine Sandoz 3 mg hard capsules EU/1/09/599/005-007 |
Rivastigmine hydrogen tartrate |
Sandoz Pharmaceuticals GmbH |
— |
| Rivastigmine Sandoz 4.5 mg hard capsules EU/1/09/599/009-011 |
Rivastigmine hydrogen tartrate |
Sandoz Pharmaceuticals GmbH |
— |
| Rivastigmine Sandoz 6 mg hard capsules EU/1/09/599/013-015 |
Rivastigmine hydrogen tartrate |
Sandoz Pharmaceuticals GmbH |
— |
| Rixathon 100 mg concentrate for solution for infusion EU/1/17/1185/001-002 |
Rituximab |
Sandoz GmbH |
— |
| Rixathon 500 mg concentrate for solution for infusion EU/1/17/1185/003-004 |
Rituximab |
Sandoz GmbH |
— |
| Riximyo 100 mg concentrate for solution for infusion EU/1/17/1184/001-002 |
Rituximab |
Sandoz GmbH |
— |
| Riximyo 500 mg concentrate for solution for infusion EU/1/17/1184/003-004 |
Rituximab |
Sandoz GmbH |
— |
| RIXUBIS 1000 IU powder and solvent for solution for injection EU/1/14/970/003 |
Nonacog gamma |
Baxter Innovations GmbH |
— |
| RIXUBIS 2000 IU powder and solvent for solution for injection EU/1/14/970/004 |
Nonacog gamma |
Baxter Innovations GmbH |
— |
| RIXUBIS 250 IU powder and solvent for solution for injection EU/1/14/970/001 |
Nonacog gamma |
Baxter Innovations GmbH |
— |
| RIXUBIS 3000 IU powder and solvent for solution for injection EU/1/14/970/005 |
Nonacog gamma |
Baxter Innovations GmbH |
— |
| RIXUBIS 500 IU powder and solvent for solution for injection EU/1/14/970/002 |
Nonacog gamma |
Baxter Innovations GmbH |
— |
| Rizmoic 200 microgram Film-coated tablet EU/1/18/1291/001-003 |
Naldemedine tosilate |
Shionogi B.V. |
— |
| RoActemra 162 mg Solution for injection EU/1/08/492/007-008 |
Tocilizumab |
Roche Registration GmbH |
— |
| RoActemra 162 mg Solution for injection EU/1/08/492/009-010 |
Tocilizumab |
Roche Registration GmbH |
— |
| RoActemra 20 mg/ml Concentrate for solution for infusion EU/1/08/492/001-006 |
Tocilizumab |
Roche Registration GmbH |
— |
| Robitussin Plus Oral Solution Guaifenesin 100 mg/5ml Pseudoephedrine HCl 30 mg/5ml PA0678/154/001 |
Guaiphenesin, PSEUDOEPHEDRINE HYDROCHLORIDE |
Haleon Ireland Limited |
Not marketed |
| Roclanda 50 micrograms/ml + 200 micrograms/ml eye drops, solution EU/1/20/1502/001 |
NETARSUDIL MESILATE, NETARSUDIL, Latanoprost |
Santen OY |
— |
| ROCTAVIAN 2 × 10^13 vector genomes/mL solution for infusion EU/1/22/1668/001 |
Valoctocogene Roxaparvovec |
Biomarin International Limited |
— |
| Rocuronium 10 mg/ml solution for injection/infusion PA2059/018/001 |
Rocuronium bromide |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Rolcya 60 mg solution for injection in pre-filled syringe EU/1/25/1958/001 |
Denosumab |
Sandoz GmbH |
— |
| Rolufta Ellipta 55 micrograms inhalation powder, pre-dispensed EU/1/17/1174/001-003 |
Umeclidinium bromide |
GlaxoSmithKline Trading Services Limited |
— |
| ROMVIMZA 14 mg hard capsules EU/1/25/1968/001 |
Vimseltinib |
Deciphera Pharmaceuticals (Netherlands) B.V. |
— |
| ROMVIMZA 20 mg hard capsules EU/1/25/1968/002 |
Vimseltinib |
Deciphera Pharmaceuticals (Netherlands) B.V. |
— |
| ROMVIMZA 30 mg hard capsules EU/1/25/1968/003 |
Vimseltinib |
Deciphera Pharmaceuticals (Netherlands) B.V. |
— |
| Ropivacaine 2 mg/ml solution for injection PA2059/021/001 |
Ropivacaine Hydrochloride |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Ropivacaine 7.5 mg/ml solution for injection PA2059/021/002 |
Ropivacaine Hydrochloride |
Fresenius Kabi Deutschland GmbH |
Not marketed |
| Rosuvastatin Rowa 10 mg film-coated tablets PA0074/093/002 |
Rosuvastatin |
Rowa Pharmaceuticals Limited, |
Marketed |
| Rosuvastatin Rowa 20 mg film-coated tablets PA0074/093/003 |
Rosuvastatin |
Rowa Pharmaceuticals Limited, |
Marketed |
| Rosuvastatin Rowa 40 mg film-coated tablets PA0074/093/004 |
Rosuvastatin |
Rowa Pharmaceuticals Limited, |
Marketed |
| Rosuvastatin Rowa 5 mg film-coated tablets PA0074/093/001 |
Rosuvastatin |
Rowa Pharmaceuticals Limited, |
Marketed |
| Rotarix oral suspension in pre-filled oral applicator EU/1/05/330/5-11 |
Human rotavirus, live attenuated |
GlaxoSmithKline Biologicals S.A. |
— |
| RotaTeq oral solution Rotavirus vaccine (live) EU/1/06/348/01 |
Rotavirus vaccine, live, pentavalent gi, Rotavirus vaccine, live, pentavalent g2, Rotavirus vaccine, live, pentavalent g3, Rotavirus vaccine, live, pentavalent g4, Rotavirus vaccine, live, pentavalent p1 |
Merck Sharp & Dohme BV, |
— |
| Roteas 15 mg film-coated tablets EU/1/16/1152/001-002 |
Edoxaban tosilate |
Berlin-Chemie AG |
— |
| Roteas 30 mg film-coated tablets EU/1/16/1152/003-015 |
Edoxaban tosilate |
Berlin-Chemie AG |
— |
| Roteas 60 mg film-coated tablets EU/1/16/1152/016-028 |
Edoxaban tosilate |
Berlin-Chemie AG |
— |
| Rowachol Gastro-resistant Capsules, Soft PA0074/008/001 |
Menthol, Menthone, Alpha pinene, Borneol, Cineole |
Rowa Pharmaceuticals Limited, |
Marketed |
| Rowachol Oral Drops, Solution PA0074/008/002 |
Alpha pinene, Borneol, Menthol, Beta pinene, Menthone |
Rowa Pharmaceuticals Limited, |
Not marketed |
| Rowalief 500 mg Film-coated tablets PA0074/065/001 |
Paracetamol |
Rowa Pharmaceuticals Limited, |
Marketed |
| Rowalief Max 1000 mg film-coated tablets PA0074/065/002 |
Paracetamol |
Rowa Pharmaceuticals Limited, |
Not marketed |
| Rowarolan Cutaneous Powder PA0074/046/001 |
Calcium carbonate |
Rowa Pharmaceuticals Limited |
Marketed |